Status:

COMPLETED

Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors

Lead Sponsor:

Ohio State University Comprehensive Cancer Center

Conditions:

Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity

Stage I Squamous Cell Carcinoma of the Oropharynx

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

This pilot clinical trial studies freeze-dried black raspberries (BRB) in preventing oral cancer recurrence in high at-risk Appalachian patients previously treated with surgery for oral cancer. Chemop...

Detailed Description

PRIMARY OBJECTIVES: I. To conduct an initial early phase clinical study utilizing a high ar-risk and underserved Appalachian population who are former oral cancer patients to determine the practicabi...

Eligibility Criteria

Inclusion

  • Patients from any Appalachian County with previously diagnosed, biopsy-proven, surgically resected, oral squamous cell carcinoma (SCC) (stages T1 to T4), which encompasses cancers of the oral cavity including lips, buccal mucosa, teeth, floor of the mouth and gums and those of the oropharynx consisting of the base of the tongue, soft palate, tonsillar area, and the posterior pharyngeal wall will be eligible
  • Patients who have followed the advice of their physician and have been definitively treated for their tumor by any method and are currently disease free will be eligible
  • Patients may be enrolled as early as their first follow-up post-operative clinic visit after their most recent surgery, but no more than 36 months post-surgery
  • Patients must be able to take nutrition/medications orally
  • No prior history of intolerance or allergy to berry or berry-containing products

Exclusion

  • History of intolerance (including hypersensitivity or allergy) to berry or berry-containing products
  • Patients who are actively receiving adjuvant therapy (radiation, chemotherapy) will be excluded until such time as they have completed treatments
  • Pregnant women; although there are no known adverse effects of black raspberries upon the fetus, if patients become pregnant during period of LBR administration, then LBR will be discontinued and patient will be removed from the study
  • Inability to grant informed consent

Key Trial Info

Start Date :

February 23 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 22 2015

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT01504932

Start Date

February 23 2007

End Date

April 22 2015

Last Update

February 20 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ohio State University Medical Center

Columbus, Ohio, United States, 43210